Publications by authors named "P V Houtte"
Purpose / Objective: This study compares the dosimetric plans of three distinct boost modalities in cervical cancer (CC): intracavitary (IC) with tandem/ovoids brachytherapy (BT), IC + interstitial (IS) BT, and Stereotactic-Body-Radiotherapy (SBRT). The aim is to determine the dosimetric impact in terms of target coverage and organ at risk (OAR) doses.
Materials And Methods: 24 consecutive IC + IS BT boost treatment plans were retrospectively identified.
International consensus on radiotherapy in metastatic non-small cell lung cancer.
Transl Lung Cancer Res
September 2022
Article Synopsis
- Lung cancer, particularly non-small cell lung cancer (NSCLC), is the top cause of cancer-related deaths globally, and advancements in radiotherapy and new therapies are enhancing treatment options beyond just palliative care.
- A group of international radiotherapy experts worked together to develop evidence-based recommendations for the use of radiotherapy in patients with metastatic NSCLC, focusing on personalized patient management.
- Radiotherapy can provide quick symptom relief and improve survival rates when used correctly, especially for patients with fewer metastases or brain metastases; however, further research is needed to determine the best treatment combinations and strategies.
We report the case of a 50-year old women with an oncological history of metastatic breast carcinoma who underwent lung stereotactic body radiation therapy (SBRT) of 60Gy in 8 fractions for a left upper lobe metastatic lesion. Seven months later, she complains about hoarseness and weakness of voice. Tumoral relapse and other frequent etiologies were excluded.
View Article and Find Full Text PDFBackground: Large part of patients of stage IB non-small cell lung cancer (IB NSCLC) may suffer recurrence after surgery. This study is to determine risk factors and establish a nomogram for postoperative recurrence and to provide a reference for adjuvant chemotherapy selection in patients with stage IB NSCLC.
Methods: A total of 394 patients with postoperative stage IB NSCLC who visited Fujian Medical University Union Hospital between January 2010 and June 2016 were selected.
Background: The role of postoperative radiation therapy (PORT) in stage III N2 NSCLC is controversial. We analyzed decision-making for PORT among European radiation oncology experts in lung cancer.
Methods: Twenty-two experts were asked before and after presentation of the results of the LungART trial to describe their decision criteria for PORT in the management of pN+ NSCLC patients.